BFLY
Butterfly Network, Inc. [BFLY] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BFLY Stock Summary
Top 10 Correlated ETFs
BFLY
Top 10 Correlated Stocks
BFLY
In the News
BFLY Financial details
Company Rating
Neutral
Market Cap
185.11M
Income
-133.7M
Revenue
65.9M
Book val./share
1.06
Cash/share
0.65
Dividend
-
Dividend %
-
Employees
225
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-1.96
Forward P/E
-
PEG
0.87
P/S
3.54
P/B
0.94
P/C
1.27
P/FCF
-2.02
Quick Ratio
3.61
Current Ratio
5.92
Debt / Equity
0.11
LT Debt / Equity
0.1
-
-
EPS (TTM)
-0.65
EPS next Y
-
EPS next Q
-
EPS this Y
-22.62%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-47.98%
Revenue last 5Y
19.03%
Revenue Q/Q
7.1%
EPS Q/Q
61.54%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
36.01%
Inst Trans
0.85%
ROA
-37%
ROE
-43%
ROC
-0.51%
Gross Margin
57%
Oper. Margin
-216%
Profit Margin
-180%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.761-2.9
52W High
-
52W Low
-
RSI
36
Rel Volume
0.62
Avg Volume
1.68M
Volume
1.05M
Perf Week
-14.68%
Perf Month
-35.67%
Perf Quarter
-0.42%
Perf Half Y
0.8%
-
-
-
-
Beta
2.039
-
-
Volatility
0.05%, 0.09%
Prev Close
0.49%
Price
0.8234
Change
-8.06%
BFLY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 4.72 | 7.64 | 0.36 | 0.37 | 0.32 | |
| Net income per share | -17.06 | -26.87 | -0.19 | -0.84 | -0.65 | |
| Operating cash flow per share | -20.63 | -13.49 | -1.09 | -0.85 | -0.48 | |
| Free cash flow per share | -21.39 | -13.88 | -1.13 | -0.94 | -0.51 | |
| Cash per share | 15.42 | 9.94 | 2.43 | 1.19 | 0.66 | |
| Book value per share | 25.46 | -59.76 | 2.58 | 1.63 | 1.07 | |
| Tangible book value per share | 25.66 | -59.76 | 2.58 | 1.63 | 1.02 | |
| Share holders equity per share | 25.46 | -59.76 | 2.58 | 1.63 | 1.07 | |
| Interest debt per share | 0 | 16.15 | 0.17 | 0.16 | 0.12 | |
| Market cap | 57.8M | 119.86M | 1.16B | 491.63M | 221.82M | |
| Enterprise value | -32.2M | 113.55M | 767.64M | 360.96M | 112.21M | |
| P/E ratio | -0.58 | -0.74 | -35.88 | -2.91 | -1.66 | |
| Price to sales ratio | 2.1 | 2.59 | 18.59 | 6.7 | 3.37 | |
| POCF ratio | -0.48 | -1.47 | -6.15 | -2.91 | -2.24 | |
| PFCF ratio | -0.46 | -1.43 | -5.9 | -2.62 | -2.12 | |
| P/B Ratio | 0.39 | -0.33 | 2.6 | 1.51 | 1.01 | |
| PTB ratio | 0.39 | -0.33 | 2.6 | 1.51 | 1.01 | |
| EV to sales | -1.17 | 2.45 | 12.27 | 4.92 | 1.7 | |
| Enterprise value over EBITDA | 0.33 | -0.7 | -4.03 | -1.97 | -0.96 | |
| EV to operating cash flow | 0.27 | -1.39 | -4.06 | -2.13 | -1.14 | |
| EV to free cash flow | 0.26 | -1.35 | -3.9 | -1.93 | -1.07 | |
| Earnings yield | -1.72 | -1.36 | -0.03 | -0.34 | -0.6 | |
| Free cash flow yield | -2.16 | -0.7 | -0.17 | -0.38 | -0.47 | |
| Debt to equity | 0 | -0.27 | 0.06 | 0.1 | 0.11 | |
| Debt to assets | 0 | 0.66 | 0.05 | 0.08 | 0.08 | |
| Net debt to EBITDA | 0.91 | 0.04 | 2.07 | 0.71 | 0.94 | |
| Current ratio | 7.13 | 1.4 | 10.27 | 6.96 | 5.22 | |
| Interest coverage | 0 | -141.65 | -296.05 | -96.51K | 0 | |
| Income quality | 1.21 | 0.5 | 5.84 | 1 | 0.74 | |
| Dividend Yield | 0 | 0.47 | 0 | 0 | 0 | |
| Payout ratio | 0 | -0.35 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.66 | 0.53 | 1.37 | 1.14 | 0.75 | |
| Research and developement to revenue | 1.77 | 1.08 | 1.19 | 1.21 | 0.84 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0.03 | |
| Capex to operating cash flow | 0.04 | 0.03 | 0.04 | 0.11 | 0.06 | |
| Capex to revenue | -0.16 | -0.05 | -0.13 | -0.25 | -0.09 | |
| Capex to depreciation | -5.89 | -1.81 | -3.77 | -3.08 | -0.66 | |
| Stock based compensation to revenue | 0.22 | 0.24 | 0.76 | 0.58 | 0.42 | |
| Graham number | 98.87 | 190.08 | 3.29 | 5.56 | 3.96 | |
| ROIC | -0.69 | 0.61 | -0.38 | -0.5 | -0.47 | |
| Return on tangible assets | -0.6 | -1.11 | -0.06 | -0.4 | -0.45 | |
| Graham Net | 13.85 | -71.28 | 1.87 | 0.93 | 0.48 | |
| Working capital | 93.93M | 27.64M | 462.08M | 305.81M | 186.99M | |
| Tangible asset value | 149.81M | -361.93M | 447.69M | 325.36M | 209.74M | |
| Net current asset value | 93.93M | -411.79M | 387.63M | 264.93M | 147.04M | |
| Invested capital | 0 | -0.27 | 0.06 | 0.1 | 0.11 | |
| Average receivables | 0 | 3.85M | 8.84M | 13.31M | 14.05M | |
| Average payables | 0 | 10.78M | 11.1M | 6.5M | 6.15M | |
| Average inventory | 0 | 17.62M | 31.02M | 48.11M | 67.9M | |
| Days sales outstanding | 25.82 | 45.39 | 69.63 | 73.03 | 74.32 | |
| Days payables outstanding | 38.91 | 55.7 | 46.5 | 77.57 | 37.88 | |
| Days of inventory on hand | 71.08 | 87.64 | 290.67 | 645.12 | 564.4 | |
| Receivables turnover | 14.14 | 8.04 | 5.24 | 5 | 4.91 | |
| Payables turnover | 9.38 | 6.55 | 7.85 | 4.71 | 9.64 | |
| Inventory turnover | 5.13 | 4.16 | 1.26 | 0.57 | 0.65 | |
| ROE | -0.67 | 0.45 | -0.07 | -0.52 | -0.61 | |
| Capex per share | -0.77 | -0.39 | -0.05 | -0.09 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.09 | 0.08 | 0.09 | 0.07 | 0.08 | |
| Net income per share | -0.17 | -0.17 | -0.14 | -0.13 | -0.21 | |
| Operating cash flow per share | -0.14 | -0.21 | -0.13 | -0.08 | -0.06 | |
| Free cash flow per share | -0.15 | -0.22 | -0.13 | -0.08 | -0.08 | |
| Cash per share | 1.18 | 0.96 | 0.81 | 0.73 | 0.65 | |
| Book value per share | 1.62 | 1.46 | 1.36 | 1.25 | 1.06 | |
| Tangible book value per share | 1.62 | 1.46 | 1.36 | 1.25 | 1.01 | |
| Share holders equity per share | 1.62 | 1.46 | 1.36 | 1.25 | 1.06 | |
| Interest debt per share | 0.17 | 0.15 | 0.15 | 0.12 | 0.12 | |
| Market cap | 493.96M | 380.82M | 471.26M | 243.95M | 223.86M | |
| Enterprise value | 363.29M | 216.46M | 333.15M | 117.36M | 114.25M | |
| P/E ratio | -3.66 | -2.84 | -4.11 | -2.23 | -1.27 | |
| Price to sales ratio | 26.02 | 24.61 | 25.49 | 15.82 | 13.55 | |
| POCF ratio | -17.12 | -8.8 | -17.79 | -15.27 | -17.09 | |
| PFCF ratio | -15.94 | -8.54 | -17.22 | -14.33 | -14.34 | |
| P/B Ratio | 1.52 | 1.29 | 1.7 | 0.95 | 1.02 | |
| PTB ratio | 1.52 | 1.29 | 1.7 | 0.95 | 1.02 | |
| EV to sales | 19.14 | 13.99 | 18.02 | 7.61 | 6.92 | |
| Enterprise value over EBITDA | -7.95 | -6.61 | -11.22 | -4.37 | -2.59 | |
| EV to operating cash flow | -12.59 | -5 | -12.58 | -7.34 | -8.72 | |
| EV to free cash flow | -11.73 | -4.85 | -12.17 | -6.89 | -7.32 | |
| Earnings yield | -0.07 | -0.09 | -0.06 | -0.11 | -0.2 | |
| Free cash flow yield | -0.06 | -0.12 | -0.06 | -0.07 | -0.07 | |
| Debt to equity | 0.1 | 0.11 | 0.11 | 0.1 | 0.11 | |
| Debt to assets | 0.08 | 0.08 | 0.09 | 0.08 | 0.08 | |
| Net debt to EBITDA | 2.86 | 5.02 | 4.65 | 4.71 | 2.48 | |
| Current ratio | 6.96 | 7.2 | 6.37 | 5.92 | 5.22 | |
| Interest coverage | -27.07 | 25.27 | 0 | 0 | 0 | |
| Income quality | 0.86 | 1.29 | 0.92 | 0.58 | 0.3 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 1.42 | 0.71 | 0.79 | 0.75 | 0.75 | |
| Research and developement to revenue | 1.01 | 1.08 | 0.85 | 0.79 | 0.68 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0.03 | |
| Capex to operating cash flow | 0.07 | 0.03 | 0.03 | 0.07 | 0.19 | |
| Capex to revenue | -0.11 | -0.09 | -0.05 | -0.07 | -0.15 | |
| Capex to depreciation | -1.14 | -0.64 | -0.4 | -0.26 | -1.12 | |
| Stock based compensation to revenue | 0.8 | 0.27 | 0.54 | 0.44 | 0.4 | |
| Graham number | 2.47 | 2.33 | 2.07 | 1.93 | 2.25 | |
| ROIC | -0.13 | -0.1 | -0.09 | -0.11 | -0.17 | |
| Return on tangible assets | -0.08 | -0.09 | -0.08 | -0.08 | -0.15 | |
| Graham Net | 0.93 | 0.76 | 0.67 | 0.63 | 0.47 | |
| Working capital | 305.81M | 277.73M | 245.99M | 223.23M | 186.99M | |
| Tangible asset value | 325.36M | 296.15M | 277.71M | 257.42M | 209.74M | |
| Net current asset value | 264.93M | 236.99M | 204.95M | 191.78M | 147.04M | |
| Invested capital | 0.1 | 0.11 | 0.11 | 0.1 | 0.11 | |
| Average receivables | 13.25M | 14.08M | 15.63M | 15.71M | 13.53M | |
| Average payables | 4.94M | 6.32M | 6.91M | 8.24M | 6.59M | |
| Average inventory | 58.82M | 64.69M | 78.12M | 90.42M | 84.93M | |
| Days sales outstanding | 69.62 | 78.36 | 86.56 | 79.64 | 73.12 | |
| Days payables outstanding | 68.84 | 76.5 | 99.77 | 120.67 | 15.77 | |
| Days of inventory on hand | 572.54 | 978.02 | 1.03K | 1.4K | 234.93 | |
| Receivables turnover | 1.29 | 1.15 | 1.04 | 1.13 | 1.23 | |
| Payables turnover | 1.31 | 1.18 | 0.9 | 0.75 | 5.71 | |
| Inventory turnover | 0.16 | 0.09 | 0.09 | 0.06 | 0.38 | |
| ROE | -0.1 | -0.11 | -0.1 | -0.11 | -0.2 | |
| Capex per share | -0.01 | -0.01 | 0 | -0.01 | -0.01 |
BFLY Frequently Asked Questions
What is Butterfly Network, Inc. stock symbol ?
Butterfly Network, Inc. is a US stock , located in Guilford of Ct and trading under the symbol BFLY
What is Butterfly Network, Inc. stock quote today ?
Butterfly Network, Inc. stock price is $0.8234 today.
Is Butterfly Network, Inc. stock public?
Yes, Butterfly Network, Inc. is a publicly traded company.
Company Profile
- Volume Average 1.68M
- Market Capitalization 185.11M
- Employee 225
- CEO Mr. Joseph M. DeVivo
- Headquarters Guilford,CT,US
- IPO Date 2020-07-13
-
Website
https://www.butterflynetwork.com 
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smartphone, tablet, and hospital computer system; and Butterfly Blueprint, a system-wide ultrasound platform with Compass software that integrates into a healthcare system's clinical and administrative infrastructure. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as clinical support and services. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
